|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 45/00 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 27/04 | (2006.01) | ||
| A61K 31/436 | (2006.01) | ||
| A61K 38/13 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3439661 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17718304.3 |
| Date of filing the European patent application | 2017-04-06 | |
| (97) | Date of publication of the European application | 2019-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/026385 |
| Date | 2017-04-06 |
| (87) | Number | WO 2017/177024 |
| Date | 2017-10-12 |
| (30) | Number | Date | Country code |
| 201662319648 P | 2016-04-07 | US |
| (72) |
ACKERMANN, Douglas Michael , US
LOUDIN, James , US
MANDELL, Kenneth J. , US
|
| (73) |
Oyster Point Pharma, Inc. ,
202 Carnegie Center, Suite 109, Princeton, New Jersey 08540,
US
|
| (54) | METHODS OF TREATING OCULAR CONDITIONS |
| METHODS OF TREATING OCULAR CONDITIONS |